S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NASDAQ:NVIV

InVivo Therapeutics News Headlines

$1.40
+0.14 (+11.11 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.22
Now: $1.40
$1.47
50-Day Range
$0.59
MA: $0.78
$1.26
52-Week Range
$0.50
Now: $1.40
$10.05
Volume8.89 million shs
Average Volume6.63 million shs
Market Capitalization$29.64 million
P/E RatioN/A
Dividend YieldN/A
Beta1.9

Headlines

InVivo Therapeutics (NASDAQ NVIV) News Headlines Today

Source:
SourceHeadline
InVivo Therapeutics (NASDAQ:NVIV) Trading 5% Higher InVivo Therapeutics (NASDAQ:NVIV) Trading 5% Higher
americanbankingnews.com - January 21 at 8:02 PM
InVivo Therapeutics (NASDAQ:NVIV) Stock Price Down 9%InVivo Therapeutics (NASDAQ:NVIV) Stock Price Down 9%
americanbankingnews.com - January 20 at 3:30 AM
Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
finance.yahoo.com - January 19 at 6:11 PM
InVivo Therapeutics (NASDAQ:NVIV) Shares Up 27%InVivo Therapeutics (NASDAQ:NVIV) Shares Up 27%
americanbankingnews.com - January 15 at 6:52 PM
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Sees Large Decline in Short InterestInVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Sees Large Decline in Short Interest
americanbankingnews.com - January 13 at 4:42 PM
InVivo Therapeutics (NASDAQ:NVIV) Shares Gap Up to $0.88InVivo Therapeutics (NASDAQ:NVIV) Shares Gap Up to $0.88
americanbankingnews.com - January 11 at 9:31 AM
InVivo Therapeutics (NASDAQ:NVIV) Stock Price Up 9.5%InVivo Therapeutics (NASDAQ:NVIV) Stock Price Up 9.5%
americanbankingnews.com - January 7 at 7:26 PM
InVivo Therapeutics (NASDAQ:NVIV) Trading Down 14.6%InVivo Therapeutics (NASDAQ:NVIV) Trading Down 14.6%
americanbankingnews.com - January 7 at 12:10 AM
InVivo Therapeutics (NASDAQ:NVIV) Shares Gap Up to $0.82InVivo Therapeutics (NASDAQ:NVIV) Shares Gap Up to $0.82
americanbankingnews.com - January 5 at 10:58 AM
InVivo Therapeutics (NASDAQ:NVIV) Trading 16.8% Higher InVivo Therapeutics (NASDAQ:NVIV) Trading 16.8% Higher
americanbankingnews.com - December 30 at 6:58 PM
InVivo Therapeutics HoldingsInVivo Therapeutics Holdings
fool.com - November 25 at 6:53 PM
InVivo Therapeutics Announces Closing of $15.0 Million Public OfferingInVivo Therapeutics Announces Closing of $15.0 Million Public Offering
finance.yahoo.com - October 26 at 7:17 PM
InVivo Therapeutics under pressure on pricing $15M equity offeringInVivo Therapeutics under pressure on pricing $15M equity offering
seekingalpha.com - October 22 at 2:34 PM
Mid-Day Market Update: Crude Oil Rises 2%; InVivo Therapeutics Shares PlummetMid-Day Market Update: Crude Oil Rises 2%; InVivo Therapeutics Shares Plummet
benzinga.com - October 22 at 2:34 PM
InVivo Therapeutics Announces Pricing of $15.0 Million Public OfferingInVivo Therapeutics Announces Pricing of $15.0 Million Public Offering
finance.yahoo.com - October 22 at 9:28 AM
InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment ConferenceInVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference
finance.yahoo.com - September 11 at 8:41 AM
BRIEF-Invivo Files For Resale Of Up To 1.83 Mln Shares By The Selling StockholdersBRIEF-Invivo Files For Resale Of Up To 1.83 Mln Shares By The Selling Stockholders
www.reuters.com - May 22 at 7:21 PM
10-Q: INVIVO THERAPEUTICS HOLDINGS CORP.10-Q: INVIVO THERAPEUTICS HOLDINGS CORP.
www.marketwatch.com - May 15 at 3:11 PM
InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesInVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - April 17 at 4:14 PM
InVivo Therapeutics Holdings Corp.InVivo Therapeutics Holdings Corp.
www.barrons.com - March 31 at 10:26 PM
BRIEF-Invivo Therapeutics Announces Pricing Of $7 Mln Public OfferingBRIEF-Invivo Therapeutics Announces Pricing Of $7 Mln Public Offering
www.reuters.com - March 6 at 1:28 PM
InVivo down 56% after pricing equity offeringInVivo down 56% after pricing equity offering
seekingalpha.com - March 6 at 1:28 PM
InVivo Therapeutics Announces Pricing of $7.0 Million Public OfferingInVivo Therapeutics Announces Pricing of $7.0 Million Public Offering
finance.yahoo.com - March 6 at 1:28 PM
InVivo Therapeutics Holdings CorpInVivo Therapeutics Holdings Corp
www.bloomberg.com - February 16 at 12:58 PM
2019 Update of InVivo Therapeutics Corp - Product Pipeline Analysis - ResearchAndMarkets.com2019 Update of InVivo Therapeutics Corp - Product Pipeline Analysis - ResearchAndMarkets.com
www.businesswire.com - February 13 at 2:12 PM
InVivo to reverse split shares 1:30InVivo to reverse split shares 1:30
seekingalpha.com - February 3 at 5:57 PM
InVivo Therapeutics Announces Reverse Stock SplitInVivo Therapeutics Announces Reverse Stock Split
finance.yahoo.com - February 3 at 5:57 PM
InVivo Therapeutics Announces Closing of Public Offering of Common StockInVivo Therapeutics Announces Closing of Public Offering of Common Stock
finance.yahoo.com - November 22 at 6:25 PM
InVivo Therapeutics Announces Pricing of Public Offering of Common StockInVivo Therapeutics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - November 21 at 12:07 PM
InVivo Therapeutics Announces Proposed Public Offering of Common StockInVivo Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 18 at 12:47 PM
InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of DirectorsInVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors
finance.yahoo.com - November 12 at 9:43 AM
Biotech CEO found guilty of defrauding investorsBiotech CEO found guilty of defrauding investors
finance.yahoo.com - October 29 at 1:52 PM
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal CordInVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord
finance.yahoo.com - July 16 at 8:48 AM
InVivo postpones shareholder meetingInVivo postpones shareholder meeting
seekingalpha.com - July 12 at 8:30 AM
InVivo Therapeutics Announces Postponement of Annual MeetingInVivo Therapeutics Announces Postponement of Annual Meeting
finance.yahoo.com - July 12 at 8:30 AM
InVivo Therapeutics Announces Adjournment of Annual MeetingInVivo Therapeutics Announces Adjournment of Annual Meeting
finance.yahoo.com - June 14 at 11:08 AM
Five things you need to know today, and one small step for the mediaFive things you need to know today, and one small step for the media
www.bizjournals.com - May 30 at 8:34 AM
Enrollment underway in SCI study of InVivos Neuro-Spinal ScaffoldEnrollment underway in SCI study of InVivo's Neuro-Spinal Scaffold
seekingalpha.com - May 29 at 6:53 PM
Bob Langer-founded device-maker InVivo starts new trial after patient deathsBob Langer-founded device-maker InVivo starts new trial after patient deaths
finance.yahoo.com - May 29 at 6:53 PM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord InjuryInVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury
finance.yahoo.com - May 29 at 8:29 AM
InVivo up 2% premarket on new Neuro-Spinal Scaffold dataInVivo up 2% premarket on new Neuro-Spinal Scaffold data
seekingalpha.com - April 17 at 7:22 PM
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord InjuryInVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury
finance.yahoo.com - April 17 at 7:22 PM
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business UpdateInVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update
www.marketwatch.com - April 1 at 8:34 AM
Form 424B3 INVIVO THERAPEUTICS HOLD - StreetInsider.comForm 424B3 INVIVO THERAPEUTICS HOLD - StreetInsider.com
www.streetinsider.com - January 16 at 5:50 PM
InVivo Therapeutics appoints new finance chiefInVivo Therapeutics appoints new finance chief
seekingalpha.com - January 14 at 10:18 AM
InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - January 14 at 10:18 AM
This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.